Callosities

Download PDF

Recent Publications on Callosities:
Sorafenib-induced palmoplantar hyperkeratosis. Sorafenib is an oral multikinase inhibitor used in the treatment of renal...	20th June, 2008	Department of Dermatology, Geisinger Medical Center, Danville, PA 17822,	J Drugs Dermatol. 2008 Jun;7(6):588-9.
Evaluation of follow-up results of McBride operative treatment for hallux valgus deformity. Introduction Hallux valgus still remains a problem in orthopaedic surgery,...	17th June, 2008	Katedra i Klinika Ortopedii i Traumatologii Narzadu Ruchu Akademii	Ortop Traumatol Rehabil. 2008 Jun 30;10(3):261-73.
Rheumatoid forefoot reconstruction: first metatarsophalangeal joint fusion combined with Weil's metatarsal osteotomies of the lesser rays. This study evaluates the outcome of rheumatoid forefoot reconstruction...	5th June, 2008	Southampton General Hospital, Southampton University Hospitals, NHS Trust,	J Foot Ankle Surg. 2008 Mar-Apr;47(2):80-8. DOI Direct Link
Skin conditions in instrumental musicians: a self-reported survey. BACKGROUND: Instrumental musicians are a risk group for a variety of skin...	15th May, 2008	Department of Dermatology, Ruhr-University Bochum, Gudrunstr. 56, 44791	Contact Dermatitis. 2008 Apr;58(4):217-22. DOI Direct Link
Second-toe length and forefoot disorders in ballet and folk dancers. BACKGROUND: Although there is no ideal foot type for classical dancers,...	25th April, 2008	Department of Orthopaedics and Traumatology, Baskent University, and	J Am Podiatr Med Assoc. 2007 Sep-Oct;97(5):385-8.
→View more research publications.

Callosities Clinical Trials:
SOLID-Effect of Risedronate Sodium at Distal Radius in Colle's Fracture.	Colles' Fracture
Influence of Mechanical Stimulus on Distraction Osteogenesis	Leg Discrepancy
Use of Teriparatide to Accelerate Fracture Healing	Pelvic Fracture
ACTiF- Assessment of Closed Tibial Fractures	Tibial Fractures
Efficacy and Safety Study of Dermal-Living Skin Replacement to Treat Diabetic Foot Ulcers	Diabetic Foot Ulcer
→View more trials.

Callosities Patents:
US Patent No.	Title
7378433	N-[4-(heteroarylmethyl)phenyl]-heteroarylamines
5849729	Use of hydrolyzed cocoa butter for percutaneous absorption
5834290	Recombinant stratum corneum chymotryptic enzyme (SCCE)
5753612	Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists
5672508	Inhibitors of cell-cycle progression, and uses related thereto
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Callosities scientists - we have details of around 54 individuals working on Callosities .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.